Craemer Ray L MD Torrance, CA - 90504

Craemer Ray L MD is categorized under Orthopedic Doctors and Physicians in Torrance, CA and active since 1975.

Craemer Ray L MD was established in 1975, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Ray Craemer at the company’s single location by writing to 17707 Crenshaw Boulevard # 300, Torrance, California CA 90504 or by phoning (310) 217-9382. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Craemer Ray L MD
Contact Person: Ray Craemer
Address: 17707 Crenshaw Boulevard # 300, Torrance, California 90504
Phone Number: (310) 217-9382
Website Address: kappamedical.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 1975
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Orthopedic Doctors and Physicians
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Craemer Ray L MD was started in 1975 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Ray Craemer for inquiries that concern Craemer Ray L MD by calling the company number (310) 217-9382, as your correspondence is most welcome. Additionally, the physical location of the single location of Craemer Ray L MD can be found at the coordinates 33.86966,-118.32654 as well as the street address 17707 Crenshaw Boulevard # 300 in Torrance, California 90504.

For its online presence, you may visit Craemer Ray L MD’s website at kappamedical.com and engage with its social media outlets through on Twitter and on Facebook.